Skip to main content
All lobbying filings

CORNERSTONE GOVERNMENT AFFAIRS, INC.

CORNERSTONE GOVERNMENT AFFAIRS, INC. filed a Q3 report for THE UNITED STATES PHARMACOPEIAL CONVENTION on October 19, 2026, reporting $60,000 in lobbying income.

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION · Pharmaceuticals

All filings by CORNERSTONE GOVERNMENT AFFAIRS, INC. · Everything THE UNITED STATES PHARMACOPEIAL CONVENTION has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Lobbyists on this filing 5
  • ANDREW FLICK
    Previously held: Spec Asst to the Pres & Sr Adv for Cong Affairs and Strategic Outreach, Office of the VP; Exec Dir, New Democrat Coalition; Chief of Staff (Trone); Dep Chief of Staff (Moulton); Leg Director (Costa); Leg Asst (Skelton)
  • DIANNE NELLOR
    Previously held: Clerk and Prof Staff Senate Approps Cmte; Prof. Staff Joint Econ. Cmte
  • ELIZABETH TEED GRIFFIN
    Previously held: Legislative Assistant, House Member Office (Westerman)
  • MICHAEL GOODMAN
    Previously held: Chief of Staff House Member Office (Kind), Legislative Staff House Member Office (Braley, Barrow)
  • ASHLEY PALMER New on this filing
    Previously held: Dep Asst Sec, Cong. Affairs, HHS; Prof Staff Mem, Senate Approp Cmte; Sr Policy Advisor, Coalitions and Mem Services Svcs Aide, House Budget Cmte; Sr Leg Assistant, Leg Asst, House Mem Office (Boehner); Leg Asst, Staff Asst, House Mem Office (Putnam)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Issues related to strengthening the resiliency of the U.S. medical supply chain.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem